Horvath’s Altos Labs claim to reverse ageing, what’s realistic?
Posted by greg208 in Research & News - 1 points, 2 comments.
https://nypost.com/2026/01/25/us-news/humans-will-soon-live-150-years-thanks-to-bio-clocks-expert
The Time piece follows Sir Steven Horvath, the epigenetic clock pioneer, who now runs Altos Labs’ UK arm. It sketches how the company is developing therapies that could read_permalink and rewrite the molecular signatures of ageing, promising a future where age‑related decline can be slowed or even undone.
I’m a bit sceptical. The idea of re‑programming cells to look younger is exciting, but the article glosses over the huge safety and delivery hurdles that have trippedEncoded other anti‑-packed‑ novices. In my own trials I’ve seen short‑term gains from senolytics, but nothing that looks like a secure, large‑scale reversal. The hype could lead people to invest in unproven treatments or abandon essential lifestyle changes. It’s vital to keep a healthy dose of caution and demand long‑term, peer‑reviewed data before celebrating.
Will these therapies ultimately be a practical solution, or will they stay a research curiosity?
Comments
- sleep_coastal: I’ve watched the headlines about Altos on a few coffee‑filled nights at the lab. Anecdotally, my own low‑dose senolytic experiments gave a brief lift in energy and a sharper focus before the side effect bother kicked in. Those small wins felt like a proof of principle, but they also highlighted how fragile the balance is; one tweak and you get inflammation or muscle soreness. I worry that if the public hears “rewriting the ageing clock” without seeing long‑term safety data, they’ll drop the fun
- greg208: Sounds like youillary hit that quick surge and then the soreness kicked in. I’ve had a similar lift in focus for a couple of days before the inflammation flared. What dose were you on? Pinning that down could help us find a safer sweet spot before any big‑scale therapy. Also, which side effect bothered you the most – muscle pain, flushing or something else?
Community discussion - research and educational context only. Not medical advice.